Lorazepam dose-dependently decreases risk-taking related activation in limbic areas.
| Publicado en: | Psychopharmacology Vol. 189; no. 1; pp. 105 - 117 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2006
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104333946&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104333946 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00333158 EJD jtl: Psychopharmacology issn: 00333158 maglogo: N pubinfo: dt: Nov2006 vid: 189 iid: 1 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104333946 2011955269 10.1007/s00213-006-0519-8 104333946 ppf: 105 ppct: 12 formats: fmt: @attributes: type: P tig: atl: Lorazepam dose-dependently decreases risk-taking related activation in limbic areas. aug: au: Arce, Estibaliz Miller, Daniel A. Feinstein, Justin S. Stein, Murray B. Paulus, Martin P. affil: Department of Psychiatry, Laboratory of Biological Dynamics and Theoretical Medicine , University of California San Diego , 8950 Villa La Jolla Dr., Suite C213 La Jolla 92037-0985 USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|